Registration Strip Icon for alerts 실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.

APYX

Apyx Medical (APYX)

Apyx Medical Corporation
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:APYX
일자시간출처헤드라인심볼기업
2024/06/2620:30PR Newswire (US)Apyx Medical Corporation Launches the "Renewing Lives" Give-Back Campaign Providing Treatments with Renuvion to Benefit Physical Appearance and Mental HealthNASDAQ:APYXApyx Medical Corporation
2024/06/0103:49Edgar (US Regulatory)Form SD - Specialized disclosure reportNASDAQ:APYXApyx Medical Corporation
2024/05/1001:14Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:APYXApyx Medical Corporation
2024/05/0923:05Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:APYXApyx Medical Corporation
2024/05/0920:45Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:APYXApyx Medical Corporation
2024/05/0920:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:APYXApyx Medical Corporation
2024/05/0920:05Business WireApyx Medical Corporation Reports First Quarter 2024 Financial Results; Reaffirms Full Year 2024 Financial OutlookNASDAQ:APYXApyx Medical Corporation
2024/05/0920:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:APYXApyx Medical Corporation
2024/05/0920:00Business WireApyx Medical Corporation Announces Board Leadership TransitionNASDAQ:APYXApyx Medical Corporation
2024/04/2520:30Business WireApyx Medical Corporation to Release First Quarter of Fiscal Year 2024 Financial Results on May 9, 2024NASDAQ:APYXApyx Medical Corporation
2024/04/1120:30Business WireApyx Medical Corporation Showcases New Data and Treatment Insights at the Renuvion® Users’ SummitNASDAQ:APYXApyx Medical Corporation
2024/03/2120:00Business WireApyx Medical Corporation Reports Fourth Quarter and Full Year 2023 Financial Results; Introduces Full Year 2024 Financial OutlookNASDAQ:APYXApyx Medical Corporation
2024/03/0421:30Business WireApyx Medical Corporation to Release Fourth Quarter and Fiscal Year 2023 Financial Results on March 21, 2024NASDAQ:APYXApyx Medical Corporation
2024/02/2121:33Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:APYXApyx Medical Corporation
2024/02/2121:30Business WireApyx Medical Corporation Announces Renuvion to be Featured in Educational Sessions at the American Academy of Cosmetic Surgery (AACS) Scientific MeetingNASDAQ:APYXApyx Medical Corporation
2024/02/1507:06Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:APYXApyx Medical Corporation
2024/02/1505:05Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:APYXApyx Medical Corporation
2024/02/1421:32Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:APYXApyx Medical Corporation
2024/02/1400:58Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:APYXApyx Medical Corporation
2024/02/0808:55Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:APYXApyx Medical Corporation
2024/02/0301:56Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:APYXApyx Medical Corporation
2024/01/2323:52Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:APYXApyx Medical Corporation
2024/01/2323:49Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:APYXApyx Medical Corporation
2024/01/2222:13Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:APYXApyx Medical Corporation
2024/01/2221:30Business WireApyx Medical Corporation Announces Peer-Reviewed Clinical Publication Evaluating the Safety of Renuvion® Following Liposuction in Multiple Areas of the BodyNASDAQ:APYXApyx Medical Corporation
2024/01/1206:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:APYXApyx Medical Corporation
2024/01/1206:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:APYXApyx Medical Corporation
2024/01/1206:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:APYXApyx Medical Corporation
2024/01/1206:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:APYXApyx Medical Corporation
2024/01/0821:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:APYXApyx Medical Corporation
 검색 관련기사 보기:NASDAQ:APYX